Zydus Liesciences secures USFDA okay for Duchenne Muscular Dystrophy drug We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Bristol Myers Squibb BMS 986446 gets USFDA fast track designation for Alzheimer’s Disease We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Lupin gets USFDA OAI status for Pithampur Unit 2 facility We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Zydus’s Sentynl Therapeutics pediatric Menkes disease drug flagged by USFDA We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Roche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis Rhapsido gets USFDA nod for chronic spontaneous urticaria We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Lupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric patients We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
San Sebastian (Spain): Pharmaceutical major Bayer has filed for approval to market its patented drug finerenone in India for treating certain heart failure patients, a potential boost in a country increasingly grappling with early onset of heart disease. Finerenone, branded as Kerendia, received USFDA approval in July 2025 for treatment of heart failure with a…
JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link